Philippines FDA Revokes Sanofi’s Product Registration For Dengvaxia; Company Appeals Decision

PhilStar: Sanofi Pasteur appeals Philippines revocation of Dengvaxia’s certificate of product registration
“Pharmaceutical firm Sanofi Pasteur said it has filed for a motion for reconsideration after the country’s Food and Drug Administration permanently revoked the certificates of product registration of dengue vaccine Dengvaxia. FDA Director General Nela Charade Puno on Tuesday said the pharmaceutical company has shown complete disregard of government rules and regulations…” (2/19).

Additional coverage of this story is available from Bloomberg, PhilStar, and Reuters.